Home Research Comparison of Clinical Efficacy and Safety of Tirzepatide,… Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials Systematic review published in Advances in therapy (2026) covering Liraglutide, Semaglutide, Tirzepatide.
Systematic review. Cited by 1 other paper.
The record Journal: Advances in therapy 43(5): 2090-2105 Published: 2026-05-01 PMID: 41820778 — DOI: 10.1007/s12325-026-03523-5 MeSH terms: Humans, Diabetes Mellitus, Type 2, Obesity, Weight Loss, Anti-Obesity Agents, Hypoglycemic Agents, Treatment Outcome, Bayes Theorem, Glucagon-Like Peptides, Randomized Controlled Trials as Topic, Liraglutide, Glucagon-Like Peptide-1 Receptor Agonists, Tirzepatide, Semaglutide Funding: Eli Lilly and Company Author countries: Spain, UK, USA Peptide profiles: Liraglutide , Semaglutide , Tirzepatide .
All indexed evidence: Liraglutide trials & papers , Semaglutide trials & papers , Tirzepatide trials & papers .
Related studies: Long-term effects of weight-reducing drugs in people with hypertension , Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and… , Weight Loss-Dependent Changes in Body Composition and Bone Health in People With Obesity… , GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of… .